MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10555-019-09826-0.pdf
Reference31 articles.
1. Kato, M., & Manabe, A. (2018). Treatment and biology of pediatric acute lymphoblastic leukemia. Pediatrics International, 60(1), 4–12. https://doi.org/10.1111/ped.13457.
2. Hudson, M. M., Link, M. P., & Simone, J. V. (2014). Milestones in the curability of pediatric cancers. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 32(23), 2391–2397. https://doi.org/10.1200/JCO.2014.55.6571.
3. Raetz, E. A., & Bhatla, T. (2012). Where do we stand in the treatment of relapsed acute lymphoblastic leukemia? Hematology. American Society of Hematology. Education Program, 2012, 129–136. https://doi.org/10.1182/asheducation-2012.1.129.
4. Hanna, J., Hossain, G. S., & Kocerha, J. (2019). The potential for microRNA therapeutics and clinical research. Frontiers in Genetics, 10, 478. https://doi.org/10.3389/fgene.2019.00478.
5. Petrescu, G. E. D., Sabo, A. A., Torsin, L. I., Calin, G. A., & Dragomir, M. P. (2019). MicroRNA based theranostics for brain cancer: basic principles. Journal of Experimental & Clinical Cancer Research, 38(1), 231. https://doi.org/10.1186/s13046-019-1180-5.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia;Blood Advances;2023-12-21
2. Childhood Acute Lymphoblastic Leukemia;Reference Module in Biomedical Sciences;2023
3. Construction of three‐gene‐based prognostic signature and analysis of immune cells infiltration in children and young adults with B‐acute lymphoblastic leukemia;Molecular Genetics & Genomic Medicine;2022-05-23
4. MicroRNA gene methylation landscape in pediatric B-cell precursor acute lymphoblastic leukemia;Advances in Clinical and Experimental Medicine;2022-01-29
5. MicroRNA childhood cancer catalog (M3Cs): a resource for translational bioinformatics toward health informatics in pediatric cancer;Database;2022-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3